ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma

Abstract

Using a molecular-driven selection of biomarkers, we identified ESM1 as a reliable microenvironment immunohistochemical marker of MTM-HCC. The results represent a step toward the implementation of HCC morpho-molecular subtyping into clinical practice.